At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Advisor operating in the Health Diagnostics space. If you think a Advisor is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation โ Operating as a key part in an extremely innovative business or startup.
- Growth โ Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management โ Showing exceptional management skills.
- Societal impact โ Putting their business on the map for their positive societal or environmental impact.
Our Data โ We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Tim Carter
Advisor Brand and Marketing of Baby2Body
Follow Tim Carter:
About : Baby2Body is a fully automated health, fitness and wellbeing coaching platform for pregnant women and mothers.
Martin Landaluce
Strategic Advisory Board of Broadview Ventures
Martin Landaluce, a member of Broadviewโs Strategic Advisory Board, has also been a member of the Fondation Leducq Board of Directors for 10 years, and serves as its treasurer. His responsibilities include the financial management of the Foundation, and the coordination of activities with the Leducq Trust, where he oversees investment and spending policies and handles the legal matters of the Trust and its underlying companies.
Follow Martin Landaluce:
About : Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Kim Fox
Strategic Advisory Board of Broadview Ventures
Kim Fox, MD, a member of Broadviewโs Strategic Advisory Board, is a Consultant Cardiologist and Director of Cardiology at the Royal Brompton Hospital and Professor of Clinical Cardiology, Imperial College. Professor Fox has published over 400 papers in leading scientific journals. His expertise is in the understanding, investigation and treatment of angina; he has played a major role in many important international clinical trials (EUROPA, HPS, ASCOT etc) that have revolutionized the treatment of this condition. He is the acknowledged European expert in this field and consequently chairs the Task Force producing the European Angina Guidelines and chairs the committee responsible for the audit for the management of these patients in Europe. Professor Fox has given plenary lectures to National Societies all over the world. He has given the โFinlayson Lectureโ to the Royal College of Surgeons in Glasgow, the โSt Cyres Lectureโ to the British Cardiac Society and the โAndrea Cissalpino Lectureโ to the Italian Society of Cardiology. Professor Fox has been elected an honorary member of the French Cardiac Society and Japanese Circulation Society for his services to cardiology.
Follow Kim Fox:
About : Broadview Ventures invests in businesses that focus on the development of technology solutions in cardiovascular and neurovascular diseases.
Richard Girling
Advisor of Hikma Ventures
Follow Richard Girling:
About : Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Peter Dobson
Advisor of Adaptix Ltd
Follow Peter Dobson:
About : Adaptix is transforming planar X-ray โ the diagnostic imaging modality most widely used in healthcare worldwide.
Peter Dobson
Advisor of Adaptix Ltd
Follow Peter Dobson:
About : Adaptix is transforming planar X-ray โ the diagnostic imaging modality most widely used in healthcare worldwide.
Raphael Hauser
Advisor of Adaptix Ltd
Follow Raphael Hauser:
About : Adaptix is transforming planar X-ray โ the diagnostic imaging modality most widely used in healthcare worldwide.
Toks Oyegunle
Advisor of OaCP
Follow Toks Oyegunle:
About : OaCP reduces cancerโ genetic tests time from 3 days to 2 hours and the cost by 50% with its chemical reagents.